FDA Approved: ATELVIA — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Atelvia (risendronate sodium) from Allergan, Inc., signaling an update to the product's labeling/indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• ATELVIA (RISENDRONATE SODIUM)

Snippet

SUPPL AP for ATELVIA (RISEDRONATE SODIUM)